89bio Provides Business Outlook for 2021
January 05, 2021 08:00 ET
|
89bio, Inc.
-Phase 2b NASH trial as part of a potential Phase 2b/3 program expected to initiate in 1H21- -Topline data from recently initiated NASH paired-biopsy, open-label histology cohort expected by YE21- ...
HTG Molecular Diagnostics Announces Certain Preliminary 2020 Unaudited Financial Results
January 05, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
Preliminary full year 2020 unaudited revenue of $8.5 million Cash, cash equivalents and short-term marketable securities of $28.7 million as of December 31, 2020 TUCSON, Ariz., Jan. 05, 2021 ...
VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week
January 05, 2021 08:00 ET
|
VYNE Therapeutics Inc.
BRIDGEWATER, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will participate...
Flowr and Hawthorne Canada Jointly Announce the Completion of the World’s First Cannabis Research and Development Facility of its Kind
January 05, 2021 08:00 ET
|
The Flowr Corporation
TORONTO and PORT WASHINGTON, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- North America’s first research and development facility dedicated to advancing cannabis cultivation techniques and systems has...
Vir Biotechnology to Present at 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021 08:00 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...
Replimune Announces First Patient Dosed with RP3 in a Phase 1 Clinical Trial in Patients with Advanced Solid Tumors
January 05, 2021 08:00 ET
|
Replimune Group Inc
WOBURN, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform,...
Flowr and Hawthorne Canada Jointly Announce the Completion of the World’s First Cannabis Research and Development Facility of its Kind
January 05, 2021 08:00 ET
|
Hawthorne Gardening Company
TORONTO and PORT WASHINGTON, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- North America’s first research and development facility dedicated to advancing cannabis cultivation techniques and systems has...
Cocrystal Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
January 05, 2021 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
Equillium to Present at the H.C. Wainwright Virtual BioConnect Conference
January 05, 2021 08:00 ET
|
Equillium
LA JOLLA, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders,...
AzurRx BioPharma to Participate in 10th Annual LifeSci Partners Corporate Access Event
January 05, 2021 08:00 ET
|
AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., Jan. 05, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a company specializing in the development of targeted,...
- June 17, 2024 07:30 ET Else Nutrition Completes Rollout of Novel Ready-to-Drink Kids Shakes in 276 Stores of Major Midwest Retailer
- June 17, 2024 07:30 ET Aqua-Tots Swim School Launches Newest Year-Round Location in North Canton, Ohio